+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lorcaserin"

From
Antiobesity Market Report 2025 - Product Thumbnail Image

Antiobesity Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Lorcaserin is a prescription anti-obesity drug used to treat overweight and obese adults. It works by activating serotonin receptors in the brain, which helps to reduce appetite and promote feelings of fullness. It is typically prescribed in combination with a reduced-calorie diet and increased physical activity. Common side effects include nausea, headache, dizziness, and fatigue. The lorcaserin market is a rapidly growing segment of the anti-obesity drug market. It is expected to benefit from the increasing prevalence of obesity and the growing awareness of the health risks associated with it. Additionally, the increasing availability of generic versions of lorcaserin is expected to drive market growth. Some of the major companies in the lorcaserin market include Arena Pharmaceuticals, Eisai Co., Ltd., Orexigen Therapeutics, Inc., and Vivus, Inc. Show Less Read more